DROXIA 6335 DROXIA 6335 (Droxia 200 mg)
Generic Name: hydroxyurea
Pill with imprint DROXIA 6335 DROXIA 6335 is Green, Capsule-shape and has been identified as Droxia 200 mg. It is supplied by Bristol-Myers Squibb.
Droxia is used in the treatment of anemia, sickle cell; solid tumors and belongs to the drug class antimetabolites. There is positive evidence of human fetal risk during pregnancy. Droxia 200 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for DROXIA 6335 DROXIA 6335
Droxia
- Generic Name:
- hydroxyurea
- Imprint:
- DROXIA 6335 DROXIA 6335
- Strength:
- 200 mg
- Color:
- Green
- Size:
- 16.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Antimetabolites
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Bristol-Myers Squibb
- Inactive Ingredients:
- citric acid monohydrate
gelatin
lactose
magnesium stearate
sodium phosphate
titanium dioxide
FD&C Blue No. 1
FD&C Green No. 3
Note: Inactive ingredients may vary.
More about Droxia (hydroxyurea)
- Droxia Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- Drug class: antimetabolites
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
